Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's disease.

Purpose: FDG-PET is an established supportive biomarker in dementia with Lewy bodies (DLB), but its diagnostic accuracy is unknown at the mild cognitive impairment (MCI-LB) stage when the typical metabolic pattern may be difficultly recognized at the individual level. Semiquantitative analysis of sc...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 49; no. 4; pp. 1263 - 1275
Autores principales:	Massa, Federico, Chincarini, Andrea, Bauckneht, Matteo, Raffa, Stefano, Peira, Enrico, Arnaldi, Dario, Pardini, Matteo, Pagani, Marco, Orso, Beatrice, Donegani, Maria Isabella, Brugnolo, Andrea, Biassoni, Erica, Mattioli, Pietro, Girtler, Nicola, Guerra, Ugo Paolo, Morbelli, Silvia, Nobili, Flavio
Formato:	Journal Article
Publicado:	Springer Nature Mar2022
Acceso en línea:	Ver este registro en EBSCOhost